The combination of KLK2 and ARA70 can reduce G1 arrest of tumor cells and promote tumor proliferation by regulating p21/cdk2/cyclin D1 signaling pathway (Shang et al., 2014). The gene discussed is KLK2; the disease is neoplasm.